Early use of mycophenolate mofetil (MMF), a drug used to dampen the immune system in organ transplant recipients, may reduce the risk for severe flares in patients with newly diagnosed systemic lupus ...

Please provide your email address to receive an email when new articles are posted on . MMF demonstrated comparable safety and greater reductions in AST and ALT vs. azathioprine in autoimmune ...

Among patients with systemic lupus erythematosus (SLE) managed successfully with mycophenolate mofetil (MMF), rates of disease flare were not massively greater when the drug was withdrawn over several ...

Data from a randomized controlled trial show that mycophenolate mofetil (MMF) did not significantly reduce proteinuria in patients with IgA nephropathy (IgAN) who had failed to respond to initial ...